Evidence map›Paper›PMID 19846566›Full record

SynthesisAmerican journal of epidemiology2009

Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review.

E Taioli, M A Garza, Y O Ahn, D T Bishop, J Bost, B Budai, K Chen, F Gemignani, T Keku, C S P Lima and 10 more

Open access · bronzeAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in American journal of epidemiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 16 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 16 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Association of MTHFR C677T polymorphisms and colorectal cancer risk in Asians: evidence of 12,255 subjects.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2014
    Pooled it
  8. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 12 countries.

E TaioliSUNY Downstate Medical Center, Brooklyn, New York 11203, USA. emanuela.taioli@downstate.edu
M A Garza
Y O Ahn
D T Bishop
J Bost
B Budai
K Chen
F Gemignani
T Keku
C S P Lima
L Le Marchand
K Matsuo
V Moreno
J Plaschke
M Pufulete
S B Thomas
G Toffoli
C R Wolf
C G Moore
J Little
University of Pittsburgh · USAichi Cancer Center · JPCentro di Riferimento Oncologico · ITGlaxoSmithKline (Netherlands) · NLNational Institute of Oncology · HUSeoul National University · KRSUNY Downstate Health Sciences University · USTU Dresden · DEUniversidade Estadual de Campinas (UNICAMP) · BRUniversitat de Barcelona · ESUniversity of Hawaiʻi at Mānoa · USUniversity of Leeds · GBUniversity of Ottawa · CAUniversity of Pisa · ITZhejiang University · CN

Funding

University of Pittsburgh Clinical and Translational Science InstitutionKL2RR024154 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$22.2M
RESEARCH TRAINING COREP60MD000207 · NIMHD · UNIV OF MARYLAND, COLLEGE PARK · PI THOMAS, STEPHEN B. · 2002 to 2011
$10.8M
Priority StageP20CA132385 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAIOLI, EMANUELA · 2007 to 2009
$465k
Cancer Research UK 10589NCI NIH HHS P20 CA132385NCI NIH HHS P20 CA132385-01NCRR NIH HHS KL2 RR024154NIMHD NIH HHS 2P60MD000207-08NIMHD NIH HHS P60 MD000207
6 · The paper itself

Abstract

Worldwide, over 1 million cases of colorectal cancer (CRC) were reported in 2002, with a 50% mortality rate, making CRC the second most common cancer in adults. Certain racial/ethnic populations continue to experience a disproportionate burden of CRC. A common polymorphism in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene has been associated with a lower risk of CRC. The authors performed both a meta-analysis (29 studies; 11,936 cases, 18,714 controls) and a pooled analysis (14 studies; 5,068 cases, 7,876 controls) of the C677T MTHFR polymorphism and CRC, with stratification by racial/ethnic population and behavioral risk factors. There were few studies on different racial/ethnic populations. The overall meta-analysis odds ratio for CRC for persons with the TT genotype was 0.83 (95% confidence interval (CI): 0.77, 0.90). An inverse association was observed in whites (odds ratio = 0.83, 95% CI: 0.74, 0.94) and Asians (odds ratio = 0.80, 95% CI: 0.67, 0.96) but not in Latinos or blacks. Similar results were observed for Asians, Latinos, and blacks in the pooled analysis. The inverse association between the MTHFR 677TT polymorphism and CRC was not significantly modified by smoking status or body mass index; however, it was present in regular alcohol users only. The MTHFR 677TT polymorphism seems to be associated with a reduced risk of CRC, but this may not hold true for all populations.

Indexed as

Polymorphism, Single NucleotideColorectal NeoplasmsConfidence IntervalsEpidemiologic MethodsGene FrequencyLogistic ModelsMethylenetetrahydrofolate Reductase (NADPH2)NADPOdds RatioRisk FactorsUnited StatesMethylenetetrahydrofolate Reductase (NADPH2)NADP

Identifiers

PMID19846566
PMCPMC2781761
OpenAlexW2106613407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.